Manufacturers Life Insurance Company, The Cardiff Oncology, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 17,724 shares of CRDF stock, worth $53,703. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,724
Previous 15,487
14.44%
Holding current value
$53,703
Previous $67,000
17.91%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CRDF
# of Institutions
123Shares Held
29MCall Options Held
900KPut Options Held
234K-
Commodore Capital LP New York, NY5.38MShares$16.3 Million1.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.12MShares$9.44 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.63MShares$7.96 Million0.0% of portfolio
-
Blair William & CO Chicago, IL1.75MShares$5.31 Million0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.45MShares$4.38 Million0.01% of portfolio
About Cardiff Oncology, Inc.
- Ticker CRDF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,334,900
- Market Cap $131M
- Description
- Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...